Eolo Pharma

Eolo Pharma was born from the entrepreneurial spirit of its researchers and the illusion of bringing new treatments for metabolic and cardiovascular diseases to the market.

The company’ capacity is focused on the design, development and validation of a new family of anti-inflammatory compounds and metabolic regulators to prevent and delay these diseases.

EOLO was founded by a multidisciplinary team of entrepreneurs and researchers in different fields of medicine and biotechnology.